{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:46:16Z","timestamp":1787237176977,"version":"build-2736575974"},"reference-count":23,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.6211","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T07:22:54Z","timestamp":1527060174000},"source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of long\u2011course tacrolimus treatment for idiopathic membranous nephropathy"],"prefix":"10.3892","author":[{"given":"Jia","family":"Di","sequence":"first","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, Jiangsu 213003, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"key20200713114038_b1-etm-0-0-6211","first-page":"701","volume-title":"Massry & Glassock's textbook of nephrology","author":"Massry","year":"2001"},{"key":"key20200713114038_b2-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: Recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"key20200713114038_b3-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy","volume":"23","author":"Waldman","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key20200713114038_b4-etm-0-0-6211","first-page":"139","article-title":"KDIGO Clinical Practice Guideline for Glomerulonephritis","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key20200713114038_b5-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0272-6386(04)00809-1","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review","volume":"44","author":"Perna","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key20200713114038_b6-etm-0-0-6211","first-page":"CD004293","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome","volume":"18","author":"Schieppati","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713114038_b7-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2165\/00003495-200363120-00006","article-title":"Tacrolimus: A further update of its use in the management of organ transplantation","volume":"63","author":"Scott","year":"2003","journal-title":"Drugs"},{"key":"key20200713114038_b8-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nep.12569","article-title":"Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial","volume":"21","author":"Ramachandran","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"Suppl 1","key":"key20200713114038_b9-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"i77","DOI":"10.1093\/ndt\/gfw150.02","article-title":"Tacrolimus with corticosteroids is inferior to modified Ponticelli regimen in the management of primary membranous nephropathy: Results at 2 years of randomization","volume":"31","author":"Ramachandran","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713114038_b10-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000348475","article-title":"Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: A randomized, prospective, controlled trial","volume":"181","author":"Xu","year":"2013","journal-title":"Contrib Nephrol"},{"key":"key20200713114038_b11-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"key20200713114038_b12-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"key20200713114038_b13-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key20200713114038_b14-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2215\/CJN.07570712","article-title":"Immunosuppression for membranous nephropathy: A systematic review and meta-analysis of 36 clinical trials","volume":"8","author":"Chen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20200713114038_b15-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181ca3a7d","article-title":"Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: A multicenter randomized controlled trial","volume":"339","author":"Chen","year":"2010","journal-title":"Am J Med Sci"},{"key":"key20200713114038_b16-etm-0-0-6211","first-page":"3966","article-title":"Tacrolimus protects vascular endothelial cells from injuries caused by Ox-LDL by regulating endoplasmic reticulum stress","volume":"21","author":"Qi","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20200713114038_b17-etm-0-0-6211","first-page":"2693","article-title":"Effect of tacrolimus in idiopathic membranous nephropathy: A meta-analysis","volume":"127","author":"Santosh","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"key20200713114038_b18-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1093\/ndt\/gfm366","article-title":"Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: Results of a pilot study","volume":"22","author":"Ballarin","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713114038_b19-etm-0-0-6211","first-page":"713","article-title":"Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis","volume":"21","author":"Arikan","year":"2008","journal-title":"J Nephrol"},{"key":"key20200713114038_b20-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ndt\/gfu306","article-title":"Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus","volume":"30","author":"Caro","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key20200713114038_b21-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000348570","article-title":"Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome","volume":"91","author":"Yuan","year":"2013","journal-title":"Pharmacology"},{"key":"key20200713114038_b22-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.transproceed.2003.11.044","article-title":"Tacrolimus conversion in kidney transplant recipients: Analysis of 107 patients","volume":"36","author":"Ya\u011fmurdur","year":"2004","journal-title":"Transplant Proc"},{"key":"key20200713114038_b23-etm-0-0-6211","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5301\/jn.5000199","article-title":"Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids","volume":"26","author":"He","year":"2013","journal-title":"J Nephrol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T06:40:42Z","timestamp":1594622442000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.6211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.6211","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]}}}